AXL / USDT

AXL / BTC

AXL / TRY

JUV / TRY

JUV / USDT

JUV / USDC

SOMI / BNB

HYPER / USDC

HYPER / TRY

HYPER / USDT

AT / BNB

ZK / BTC

TNSR / TRY

TNSR / USDC

LRC / ETH

AT / TRY

TNSR / USDT

AT / USDC

GUN / USDC

GUN / TRY

ENCOMPASS DESIGN INDIA L

MAHA RASHTRA APEX COPR. L

S A TECH SOFTWARE INDIA L

TV VISION LIMITED

VIPUL LIMITED

JIWANRAM SHEODUTTRA IND L

TRANS & RECTI. LTD

AEROFLEX NEU LIMITED

DYNACONS SYS & SOLN LTD

LOKESH MACHINES LTD

MRS BECTORS FOOD SPE LTD

BHARAT RASAYAN LTD

PATEL ENGINEERING LTD

HINDUSTAN CONSTRUCTION CO

REFEX INDUSTRIES LIMITED

VDEAL SYSTEM LIMITED

C2C ADVANCED SYSTEMS LTD

VLS FINANCE LTD

VL E GOV AND IT SOL LTD

NACL INDUSTRIES LIMITED

Click here to get full coverage on Alkem Laboratories Announces Senior Management Change - TipRanks

Alkem Laboratories Announces Senior Management Change  TipRanks

Alkem Laboratories Announces Senior Management Change - TipRanks

Click here to get full coverage on Novo moves court to restrain Sun Pharma, Alkem from manufacture, sale of weight loss drug semaglutide - Moneycontrol

Novo moves court to restrain Sun Pharma, Alkem from manufacture, sale of weight loss drug semaglutide  Moneycontrol

Novo moves court to restrain Sun Pharma, Alkem from manufacture, sale of weight loss drug semaglutide - Moneycontrol

Click here to get full coverage on Alkem Laboratories Senior VP Vijay Shetty Resigns from Global Distribution Supply Chain Role - scanx.trade

Alkem Laboratories Senior VP Vijay Shetty Resigns from Global Distribution Supply Chain Role  scanx.trade

Alkem Laboratories Senior VP Vijay Shetty Resigns from Global Distribution Supply Chain Role - scanx.trade

Click here to get full coverage on PATENT—Fed. Cir.: Alkem’s vancomycin oral solution did not infringe Azurity’s liquid antibiotic formulation patent - VitalLaw.com

PATENT—Fed. Cir.: Alkem’s vancomycin oral solution did not infringe Azurity’s liquid antibiotic formulation patent  VitalLaw.com

PATENT—Fed. Cir.: Alkem’s vancomycin oral solution did not infringe Azurity’s liquid antibiotic formulation patent - VitalLaw.com

Click here to get full coverage on Jefferies upgrades Alkem Laboratories stock rating to Buy on growth pivot - Investing.com

Jefferies upgrades Alkem Laboratories stock rating to Buy on growth pivot  Investing.com

Jefferies upgrades Alkem Laboratories stock rating to Buy on growth pivot - Investing.com

Click here to get full coverage on Alkem Labs Daman facility gets 3 major, few minor observations from Malta Medicines Authority - Medical Dialogues

Alkem Labs Daman facility gets 3 major, few minor observations from Malta Medicines Authority  Medical Dialogues

Alkem Labs Daman facility gets 3 major, few minor observations from Malta Medicines Authority - Medical Dialogues

Click here to get full coverage on Is Alkem Laboratories Limited's (NSE:ALKEM) Recent Performance Tethered To Its Attractive Financial Prospects? - simplywall.st

Is Alkem Laboratories Limited's (NSE:ALKEM) Recent Performance Tethered To Its Attractive Financial Prospects?  simplywall.st

Is Alkem Laboratories Limited's (NSE:ALKEM) Recent Performance Tethered To Its Attractive Financial Prospects? - simplywall.st

Click here to get full coverage on Alkem Launches Pertjeta Biosimilar in India for HER2-positive Breast Cancer - NAVLIN DAILY

Alkem Launches Pertjeta Biosimilar in India for HER2-positive Breast Cancer  NAVLIN DAILY

Alkem Launches Pertjeta Biosimilar in India for HER2-positive Breast Cancer - NAVLIN DAILY

Click here to get full coverage on Alkem Labs shares give up gains after Malta regulatory audit ends with major and minor inspections - CNBC TV18

Alkem Labs shares give up gains after Malta regulatory audit ends with major and minor inspections  CNBC TV18

Alkem Labs shares give up gains after Malta regulatory audit ends with major and minor inspections - CNBC TV18

Click here to get full coverage on United States Epilepsy Drugs Market Trends and Company Analysis Report 2025-2033 Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health, GSK - Yahoo Finance

United States Epilepsy Drugs Market Trends and Company Analysis Report 2025-2033 Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health, GSK  Yahoo Finance

United States Epilepsy Drugs Market Trends and Company Analysis Report 2025-2033 Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health, GSK - Yahoo Finance

Click here to get full coverage on Alkem Laboratories Schedules Analyst and Investor Meetings for December 2025 - TipRanks

Alkem Laboratories Schedules Analyst and Investor Meetings for December 2025  TipRanks

Alkem Laboratories Schedules Analyst and Investor Meetings for December 2025 - TipRanks

Click here to get full coverage on 5 ‘Buy’ recommendations by Jefferies in the pharma sector with at least 15% upside- Check full list - financialexpress.com

5 ‘Buy’ recommendations by Jefferies in the pharma sector with at least 15% upside- Check full list  financialexpress.com

5 ‘Buy’ recommendations by Jefferies in the pharma sector with at least 15% upside- Check full list - financialexpress.com

Click here to get full coverage on Is Alkem Laboratories Limited a Smart Pick for Retirement Portfolios - Candlestick Trading Patterns & Free Significant Capital Appreciation - earlytimes.in

Is Alkem Laboratories Limited a Smart Pick for Retirement Portfolios - Candlestick Trading Patterns & Free Significant Capital Appreciation  earlytimes.in

Is Alkem Laboratories Limited a Smart Pick for Retirement Portfolios - Candlestick Trading Patterns & Free Significant Capital Appreciation - earlytimes.in

Click here to get full coverage on Rubicon Research Acquires Alkem Laboratories’ Pithampur Facility for ₹149 Crores to Boost U.S. Market Expansion - geneonline.com

Rubicon Research Acquires Alkem Laboratories’ Pithampur Facility for ₹149 Crores to Boost U.S. Market Expansion  geneonline.com

Rubicon Research Acquires Alkem Laboratories’ Pithampur Facility for ₹149 Crores to Boost U.S. Market Expansion - geneonline.com

Click here to get full coverage on Adroit Biomeds Shareholders divests 100% stake to Alkem Laboratories - EY

Adroit Biomeds Shareholders divests 100% stake to Alkem Laboratories  EY

Adroit Biomeds Shareholders divests 100% stake to Alkem Laboratories - EY

Click here to get full coverage on Alkem Laboratories' Daman Facility Passes GMP Inspection with Minor Observations - scanx.trade

Alkem Laboratories' Daman Facility Passes GMP Inspection with Minor Observations  scanx.trade

Alkem Laboratories' Daman Facility Passes GMP Inspection with Minor Observations - scanx.trade

Click here to get full coverage on Alkem Labs Q2 Results: Strong India, US sales lift revenue; profit, margins improve - CNBC TV18

Alkem Labs Q2 Results: Strong India, US sales lift revenue; profit, margins improve  CNBC TV18

Alkem Labs Q2 Results: Strong India, US sales lift revenue; profit, margins improve - CNBC TV18

Click here to get full coverage on Alkem Laboratories Schedules Investor Meeting for Strategic Insights - TipRanks

Alkem Laboratories Schedules Investor Meeting for Strategic Insights  TipRanks

Alkem Laboratories Schedules Investor Meeting for Strategic Insights - TipRanks

Click here to get full coverage on Biosergen AB and Alkem Laboratories’ Promising Update on Antifungal Study - TipRanks

Biosergen AB and Alkem Laboratories’ Promising Update on Antifungal Study  TipRanks

Biosergen AB and Alkem Laboratories’ Promising Update on Antifungal Study - TipRanks

Click here to get full coverage on Alkem Laboratories to Reopen Trading Window Post Financial Results Disclosure - TipRanks

Alkem Laboratories to Reopen Trading Window Post Financial Results Disclosure  TipRanks

Alkem Laboratories to Reopen Trading Window Post Financial Results Disclosure - TipRanks

Click here to get full coverage on Alkem launches Roche's breast cancer blockbuster biosimilar alternative in India - ETPharma.com

Alkem launches Roche's breast cancer blockbuster biosimilar alternative in India  ETPharma.com

Alkem launches Roche's breast cancer blockbuster biosimilar alternative in India - ETPharma.com

Click here to get full coverage on Alkem Laboratories Technical Momentum Shifts Signal Changing Market Dynamics - Markets Mojo

Alkem Laboratories Technical Momentum Shifts Signal Changing Market Dynamics  Markets Mojo

Alkem Laboratories Technical Momentum Shifts Signal Changing Market Dynamics - Markets Mojo

Click here to get full coverage on Alkem introduces advanced ceramide-boosting product for skin barrier repair - BioSpectrum India

Alkem introduces advanced ceramide-boosting product for skin barrier repair  BioSpectrum India

Alkem introduces advanced ceramide-boosting product for skin barrier repair - BioSpectrum India

Click here to get full coverage on Chartists See Breakout Potential in Alkem Laboratories Limited - Geopolitical Risk Analysis & Low Cost Portfolio Ideas - earlytimes.in

Chartists See Breakout Potential in Alkem Laboratories Limited - Geopolitical Risk Analysis & Low Cost Portfolio Ideas  earlytimes.in

Chartists See Breakout Potential in Alkem Laboratories Limited - Geopolitical Risk Analysis & Low Cost Portfolio Ideas - earlytimes.in

Click here to get full coverage on Alkem Laboratories Senior VP Rakesh Tripathi Steps Down After 8.7-Year Tenure - scanx.trade

Alkem Laboratories Senior VP Rakesh Tripathi Steps Down After 8.7-Year Tenure  scanx.trade

Alkem Laboratories Senior VP Rakesh Tripathi Steps Down After 8.7-Year Tenure - scanx.trade

Click here to get full coverage on Alkem's Enzene powers into US with $70 m investment - The Economic Times

Alkem's Enzene powers into US with $70 m investment  The Economic Times

Alkem's Enzene powers into US with $70 m investment - The Economic Times

Click here to get full coverage on Alkem Laboratories Technical Momentum Shifts Amid Mixed Indicator Signals - Markets Mojo

Alkem Laboratories Technical Momentum Shifts Amid Mixed Indicator Signals  Markets Mojo

Alkem Laboratories Technical Momentum Shifts Amid Mixed Indicator Signals - Markets Mojo

Click here to get full coverage on Alkem Q2 FY26 revenue rises 17% to Rs 4000 cr on strong international sales - ETPharma.com

Alkem Q2 FY26 revenue rises 17% to Rs 4000 cr on strong international sales  ETPharma.com

Alkem Q2 FY26 revenue rises 17% to Rs 4000 cr on strong international sales - ETPharma.com

Click here to get full coverage on Alkem expects Semaglutide trial read-out by year-end, targets first wave launch - ETPharma.com

Alkem expects Semaglutide trial read-out by year-end, targets first wave launch  ETPharma.com

Alkem expects Semaglutide trial read-out by year-end, targets first wave launch - ETPharma.com

Click here to get full coverage on Neutral ALKEM Laboratories; target of Rs 5560: Motilal Oswal - Moneycontrol

Neutral ALKEM Laboratories; target of Rs 5560: Motilal Oswal  Moneycontrol

Neutral ALKEM Laboratories; target of Rs 5560: Motilal Oswal - Moneycontrol

Click here to get full coverage on Alkem Laboratories Faces Challenges Amid Flat Financial Performance and Reduced Promoter Confidence - Markets Mojo

Alkem Laboratories Faces Challenges Amid Flat Financial Performance and Reduced Promoter Confidence  Markets Mojo

Alkem Laboratories Faces Challenges Amid Flat Financial Performance and Reduced Promoter Confidence - Markets Mojo

Click here to get full coverage on Alkem Laboratories Limited Just Recorded A 6.4% Revenue Beat: Here's What Analysts Think - simplywall.st

Alkem Laboratories Limited Just Recorded A 6.4% Revenue Beat: Here's What Analysts Think  simplywall.st

Alkem Laboratories Limited Just Recorded A 6.4% Revenue Beat: Here's What Analysts Think - simplywall.st

Click here to get full coverage on Alkem launches pertuzumab biosimilar in India for treatment of HER2-positive breast cancer - BioSpectrum India

Alkem launches pertuzumab biosimilar in India for treatment of HER2-positive breast cancer  BioSpectrum India

Alkem launches pertuzumab biosimilar in India for treatment of HER2-positive breast cancer - BioSpectrum India

Click here to get full coverage on Alkem Laboratories introduces DSS Probiotic in India to boost gut health - Business Standard

Alkem Laboratories introduces DSS Probiotic in India to boost gut health  Business Standard

Alkem Laboratories introduces DSS Probiotic in India to boost gut health - Business Standard

Click here to get full coverage on Published on: 2025-12-13 14:16:26 - earlytimes.in

Published on: 2025-12-13 14:16:26  earlytimes.in

Published on: 2025-12-13 14:16:26 - earlytimes.in

Click here to get full coverage on We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease - simplywall.st

We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease  simplywall.st

We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease - simplywall.st

Click here to get full coverage on Novo moves court to restrain Sun Pharma, Alkem from manufacture, sale of Semaglutide - drugscontrol.org

Novo moves court to restrain Sun Pharma, Alkem from manufacture, sale of Semaglutide  drugscontrol.org

Novo moves court to restrain Sun Pharma, Alkem from manufacture, sale of Semaglutide - drugscontrol.org

Click here to get full coverage on Pfizer Sues Alkem to Block Copies of Xeljanz XR Arthritis Drug - Bloomberg Law News

Pfizer Sues Alkem to Block Copies of Xeljanz XR Arthritis Drug  Bloomberg Law News

Pfizer Sues Alkem to Block Copies of Xeljanz XR Arthritis Drug - Bloomberg Law News

Click here to get full coverage on Alkem launches breast cancer biosimilar in India - The Economic Times

Alkem launches breast cancer biosimilar in India  The Economic Times

Alkem launches breast cancer biosimilar in India - The Economic Times

Click here to get full coverage on Cybersecurity incident at Alkem Labs US arm, investigation underway - Medical Dialogues

Cybersecurity incident at Alkem Labs US arm, investigation underway  Medical Dialogues

Cybersecurity incident at Alkem Labs US arm, investigation underway - Medical Dialogues

Click here to get full coverage on Do Alkem Laboratories' (NSE:ALKEM) Earnings Warrant Your Attention? - simplywall.st

Do Alkem Laboratories' (NSE:ALKEM) Earnings Warrant Your Attention?  simplywall.st

Do Alkem Laboratories' (NSE:ALKEM) Earnings Warrant Your Attention? - simplywall.st

Click here to get full coverage on Alkem Labs Q2 profit rises 11% to Rs 779 crore - Moneycontrol

Alkem Labs Q2 profit rises 11% to Rs 779 crore  Moneycontrol

Alkem Labs Q2 profit rises 11% to Rs 779 crore - Moneycontrol

Click here to get full coverage on Alkem Labs Senior Management Personnel Amit Ghare steps down - Medical Dialogues

Alkem Labs Senior Management Personnel Amit Ghare steps down  Medical Dialogues

Alkem Labs Senior Management Personnel Amit Ghare steps down - Medical Dialogues

Click here to get full coverage on Alkem Laboratories Shows Shift in Market Sentiment Amid Stable Financial Metrics - Markets Mojo

Alkem Laboratories Shows Shift in Market Sentiment Amid Stable Financial Metrics  Markets Mojo

Alkem Laboratories Shows Shift in Market Sentiment Amid Stable Financial Metrics - Markets Mojo

Click here to get full coverage on Alkem Labs transfers trade generics business to Alkem Wellness - Medical Dialogues

Alkem Labs transfers trade generics business to Alkem Wellness  Medical Dialogues

Alkem Labs transfers trade generics business to Alkem Wellness - Medical Dialogues

Click here to get full coverage on Published on: 2025-12-12 19:28:34 - earlytimes.in

Published on: 2025-12-12 19:28:34  earlytimes.in

Published on: 2025-12-12 19:28:34 - earlytimes.in

Click here to get full coverage on Meet Samprada Singh: From small medicine shop to Alkem Laboratories – How Bihar farmer’s son built Rs 26,000,00,00,000 business - news24online.com

Meet Samprada Singh: From small medicine shop to Alkem Laboratories – How Bihar farmer’s son built Rs 26,000,00,00,000 business  news24online.com

Meet Samprada Singh: From small medicine shop to Alkem Laboratories – How Bihar farmer’s son built Rs 26,000,00,00,000 business - news24online.com

Click here to get full coverage on Alkem Laboratories Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo

Alkem Laboratories Technical Momentum Shifts Amid Mixed Market Signals  Markets Mojo

Alkem Laboratories Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo

Click here to get full coverage on Buy Alkem Laboratories; target of Rs 6600: ICICI Securities - TradingView — Track All Markets

Buy Alkem Laboratories; target of Rs 6600: ICICI Securities  TradingView — Track All Markets

Buy Alkem Laboratories; target of Rs 6600: ICICI Securities - TradingView — Track All Markets

Click here to get full coverage on Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold? - The Economic Times

Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold?  The Economic Times

Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold? - The Economic Times

Click here to get full coverage on Alkem Labs Q2 profit rises 11% on strong India, international sales - Business Standard

Alkem Labs Q2 profit rises 11% on strong India, international sales  Business Standard

Alkem Labs Q2 profit rises 11% on strong India, international sales - Business Standard

Click here to get full coverage on Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4% - Moneycontrol

Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%  Moneycontrol

Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4% - Moneycontrol

Click here to get full coverage on Alkem Foundation ties with IIT-B to set up R&D centre for developing immuno therapies - ETPharma.com

Alkem Foundation ties with IIT-B to set up R&D centre for developing immuno therapies  ETPharma.com

Alkem Foundation ties with IIT-B to set up R&D centre for developing immuno therapies - ETPharma.com

Click here to get full coverage on Alkem Launches Olesoft Trucera To Strengthen Skincare Portfolio - BW Healthcare World

Alkem Launches Olesoft Trucera To Strengthen Skincare Portfolio  BW Healthcare World

ALKEM

Price Chart

Key Statistics

Technicals

About ALKEM

Latest News

Alkem Laboratories Announces Senior Management Change - TipRanks

Novo moves court to restrain Sun Pharma, Alkem from manufacture, sale of weight loss drug semaglutide - Moneycontrol

Alkem Laboratories Senior VP Vijay Shetty Resigns from Global Distribution Supply Chain Role - scanx.trade

Advanced Charts

Top Gainers

Top Losers